| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.3M | +41.9% |
| SG&A Expense | $11.7M | +21.9% |
| Operating Income | -$39.0M | -35.2% |
| Pre-tax Income | -$42.8M | -49.4% |
| Income Tax | -$60K | +0.0% |
| Net Income | -$42.8M | -49.5% |
| EPS (Basic) | -$3.50 | +13.6% |
| EPS (Diluted) | -$3.50 | +13.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | -51.9% |
| Current Assets | $10.5M | -49.1% |
| Total Assets | $12.1M | -44.1% |
| Current Liabilities | $25.4M | +358.6% |
| Total Liabilities | $25.9M | +325.0% |
| Stockholders' Equity | -$15.2M | -197.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.4M | -28.4% |
| Capital Expenditures | $864K | +282.4% |
| Investing Cash Flow | -$864K | -282.4% |
| Financing Cash Flow | $22.9M | +138.7% |
| Free Cash Flow | -$33.2M | -30.6% |